Zobrazeno 1 - 10
of 1 037
pro vyhledávání: ''
Autor:
Elizabeth Pan, Tyler J. Nelson, Juan Javier-Desloges, Rana R. McKay, Jesse Nodora, Sandip Pravin Patel, J Kellogg Parsons, Maria Elena Martinez, James D. Murphy, Ithaar Derweesh, Christopher J. Kane, A. Karim Kader, Brent S. Rose
Publikováno v:
Cancer. 128:770-777
BACKGROUND This study was done to determine the representation of minorities, women, and the elderly in National Cancer Institute (NCI) clinical trials. METHODS This is an analysis in the NCI Clinical Data Update System. Patients were evaluated in br
Publikováno v:
JCO Precis Oncol
PURPOSE National Comprehensive Cancer Network guidelines for germline genetic testing have included pancreatic cancer in the context of additional family cancer history for many years but this was not recommended for patients with pancreatic ductal a
Publikováno v:
Cancer. 128:59-64
Background Most breast cancers (BCs) in men are hormone receptor-positive. Adjuvant tamoxifen is part of the standard treatment of these patients. Small, single-institution studies have suggested that men have high rates of discontinuing adjuvant end
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
BMC Cancer
Background Previous research found that the cancer history of an individual’s sibling may be a better indicator than that of the parents. We aim to provide recommendations for opportunistic screening for individuals whose sibling had been diagnosed
Autor:
Arjun Sahgal, Umberto Ricardi, Hanbo Chen, Matthew Foote, Tithi Biswas, Kristin J. Redmond, Roi Dagan, Xuguang Chen, Darby Erler, Alexander V. Louie, Serena Badellino, Ian Poon
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6189-6198 (2021)
Cancer Medicine
Cancer Medicine
Background Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastatic disease (OMD), but the effect of metastasis timing on patient outcomes remains uncertain. Methods An international database of patients with OMD treated wi
Autor:
Gary A. Palmer, Caroline G. Epstein, Michael D. Axelson, Michael E. Salazar, Matthew Kase, Martin C. Stumpe, Calvin McCarter, Ashraf T. Hafez, Joyce O'Shaughnessy, Alexandria M. Bobe, Benjamin D. Leibowitz, Ameen A. Salahudeen, Joshua S.K. Bell, Nike Beaubier, Catherine Igartua, Robert Huether, Mark D. Pegram, Louis E. Fernandes, Ruth A. Pe Benito, Sarah Sammons
Publikováno v:
Clinical Breast Cancer. 21:e340-e361
Objective/Background We performed a retrospective analysis of longitudinal real-world data (RWD) from patients with breast cancer to replicate results from clinical studies and demonstrate the feasibility of generating real-world evidence. We also as
Autor:
Emilia Durante, Vittorina Zagonel, Antonella Facchinetti, Michele Aieta, Alberto Diminutto, Carlo Gatti, Maurizio Nicodemo, Anna Paola Fraccon, Cristina Pegoraro, Claudia Mucciarini, Alessandra Bearz, Marco Maruzzo, Francesco Massari, Vincenza Conteduca, Rita Zamarchi, Umberto Basso, Ugo De Giorgi, Carmen Barile, Elisabetta Rossi, Matteo Santoni, Pasquale Fiduccia, Alessandra Perin, Teodoro Sava
Publikováno v:
Oncologist
Background Circulating tumor cells (CTCs) correlate with adverse prognosis in patients with breast, colorectal, lung, and prostate cancer. Little data are available for renal cell carcinoma (RCC). Materials and Methods We designed a multicenter prosp
Autor:
Kadir Eser, Pinar Saip, Erdem Cubukcu, Fuat Demirelli, Ozkan Alan, Zuleyha Calikusu, Aykut Bahceci, Ali Alkan, Hacer Demir, Mahmut Büyükşimşek, Cemile Karadeniz, Erhan Gokmen, Naziye Ak, Mehmet Bilici, Altay Aliyev, Turkkan Evrensel, Oznur Bal, Atakan Demir, Özge Keskin, Nilgün Yildirim, Saadettin Kilickap, Semra Paydas, Atike Gökçen Demiray, Kezban Nur Pilanci, Ali Gökyer, Perran Fulden Yumuk, Birol Yildiz, Duygu Ilke Cikman, Ismail Beypinar, Taner Korkmaz, Sinan Yavuz, Burcu Çakar, Erkan Arpaci, Gulsah Seydaoglu, Ferhat Ferhatoglu, Ahmet Z. Sahin, Gulcan Bulut, Serkan Degirmencioglu, Cengiz Karacin, Mutlu Dogan, Havva Yesil Cinkir, Kerem Okutur, Semiha Urvay, Deniz Işik, Melih Simsek, Osman Kostek, Meltem Baykara, Salim Basol Tekin, Deniz Yamac
Publikováno v:
Cancer Investigation. 39:473-481
Aim: The aim of this study is to evaluate the efficacy and toxicity of trastuzumab emtansine (T-DM1) in cases with metastatic breast cancer (mBC) in different lines of treatment. Method: Retrospective analysis of T-DM1 results of human epidermal grow
Autor:
Alma B Pedersen, Thomas Bøjer Rasmussen, Rohini K. Hernandez, Jens Sundbøll, Anouchka Seesaghur, Peter H. Asdahl, Henrik Toft Sørensen, Kasper Adelborg
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 14, Pp 4885-4895 (2021)
Asdahl, P H, Sundbøll, J, Adelborg, K, Rasmussen, T B, Seesaghur, A M, Hernandez, R K, Sørensen, H T & Pedersen, A B 2021, ' Cardiovascular events in cancer patients with bone metastases—A Danish population-based cohort study of 23,113 patients ', Cancer Medicine, vol. 10, no. 14, pp. 4885-4895 . https://doi.org/10.1002/cam4.4027
Cancer Medicine, Vol 10, Iss 14, Pp 4885-4895 (2021)
Asdahl, P H, Sundbøll, J, Adelborg, K, Rasmussen, T B, Seesaghur, A M, Hernandez, R K, Sørensen, H T & Pedersen, A B 2021, ' Cardiovascular events in cancer patients with bone metastases—A Danish population-based cohort study of 23,113 patients ', Cancer Medicine, vol. 10, no. 14, pp. 4885-4895 . https://doi.org/10.1002/cam4.4027
Introduction The incidence of cardiovascular events among cancer patients with bone metastases is poorly understood. We examined rates of cardiovascular events among cancer patients with bone metastases and mortality following such events. Methods Us
Autor:
Caitlin C. Murphy, Danyi Xiong, Bhumika Maddineni, Ethan A. Halm, David E. Gerber, Sandi L. Pruitt, Hong Zhu, Daniel F. Heitjan, Anna Tavakkoli, Amit G. Singal
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 14, Pp 4752-4767 (2021)
Cancer Medicine, Vol 10, Iss 14, Pp 4752-4767 (2021)
Patients with previous cancer are often excluded from clinical trials despite limited evidence about their prognosis. We examined the effect of previous cancer on overall and colorectal cancer (CRC)‐specific survival of patients newly diagnosed wit